Handling & Use Protocol: Benzyl (3S)-3-Hydroxy-3-Methylpiperidine-1-Carboxylate

benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate is a chiral, Cbz-protected piperidine building block widely employed as a stereocentre-bearing synthetic intermediate in medicinal chemistry and pharmaceutical research.

Product Name

benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate

SKU

B175516

Protecting Group

Benzyloxycarbonyl (Cbz)

Stereochemistry

(3S) configuration at C-3; tertiary alcohol bearing a methyl group

Key Functional Groups

Tertiary alcohol, N-Cbz carbamate

Primary Application

Chiral intermediate for synthesis of piperidine-containing APIs and bioactive molecules

Storage Recommendation

Store under inert atmosphere at 2–8 °C, protected from moisture and light (review flag: confirm exact storage conditions from CoA)

Overview and Chemical Properties

Benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate (Aladdin SKU B175516) is a saturated, six-membered nitrogen heterocycle featuring a tertiary alcohol at the 3-position and a benzyloxycarbonyl (Cbz) group on nitrogen. The defined (3S) stereocentre makes this compound a valuable enantiopure building block for asymmetric synthesis.

The Cbz group is one of the most versatile amine-protecting groups in organic synthesis: it is stable under mildly acidic and basic conditions and can be removed cleanly by catalytic hydrogenolysis (e.g., Pd/C, H₂, atmospheric pressure), revealing the free secondary amine without disturbing the tertiary alcohol or other base-sensitive functionality.

The tertiary hydroxyl at C-3, bearing a methyl substituent, provides a handle for downstream transformations including etherification, esterification, oxidation to the ketone, or mesylation/tosylation prior to substitution, all while preserving the ring nitrogen in its protected form.

Materials and Safety Precautions

Required materials:

• Benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate (B175516)
• Anhydrous solvents appropriate to the intended reaction (e.g., DCM, THF, EtOAc, MeOH)
• Inert gas supply (nitrogen or argon) for handling under protective atmosphere
• Standard glassware, syringes, and Schlenk or glovebox equipment if moisture-sensitive conditions are required
• Appropriate personal protective equipment (PPE): lab coat, nitrile gloves, safety goggles

Safety: As with all fine chemicals, handle with care. Avoid inhalation of dust or aerosols. Consult the Safety Data Sheet (SDS) supplied with B175516 before use. Work in a well-ventilated fume hood. Although no acute hazard data specific to this compound are cited here, standard laboratory chemical hygiene practices apply.

Waste disposal: Dispose of all waste, including solvent rinses, in accordance with local institutional and regulatory guidelines for chemical waste.

Step-by-Step Experimental Protocol

Step 1 – Receipt and inspection. Upon delivery, inspect the vial for integrity. Record the batch number and lot-specific certificate of analysis (CoA). Confirm purity (typically ≥95% by HPLC or NMR; verify on CoA) and enantiomeric excess (ee) before use.

Step 2 – Storage prior to use. Transfer the compound to a desiccator or sealed container under inert gas if long-term storage is required. Store at the temperature specified on the CoA (typically 2–8 °C). Allow the vial to equilibrate to room temperature under inert atmosphere before opening to avoid condensation.

Step 3 – Solubility and solution preparation. Benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate is expected to be soluble in common organic solvents including dichloromethane (DCM), tetrahydrofuran (THF), ethyl acetate, acetonitrile, and methanol. Weigh the required amount of compound using a calibrated analytical balance in a tared vial. Dissolve in the minimum volume of the chosen anhydrous solvent and dilute to the desired concentration.

Step 4 – Cbz deprotection (hydrogenolysis, if required). Dissolve the substrate in MeOH or EtOH (ca. 0.1–0.5 M). Add Pd/C (10 wt%, ca. 10 mol% relative to substrate). Purge with H₂ (balloon, atmospheric pressure) and stir at room temperature until complete by TLC or LC-MS. Filter through Celite, rinse with solvent, and concentrate under reduced pressure to give the free amine. Note: confirm reaction conditions in primary literature for your specific substrate context.

Step 5 – Tertiary alcohol activation or functionalization (if required). For mesylation or tosylation, cool a DCM solution of the compound to 0 °C, add triethylamine (2–3 equiv.) and the sulfonyl chloride (1.1–1.5 equiv.) dropwise, and allow to warm to room temperature. Monitor by TLC. Work up with aqueous wash and purify by column chromatography as appropriate.

Step 6 – Analytical verification. Confirm product identity and purity by ¹H NMR, ¹³C NMR, HPLC, and optical rotation. Chiral HPLC is recommended to verify ee if the stereocentre is critical to the intended application.

Troubleshooting and Tips

Low yield in Cbz removal: Ensure adequate H₂ pressure and catalyst loading. Check that the solvent is free of catalyst poisons (e.g., sulfur-containing impurities). If hydrogenolysis is sluggish, consider using Pd(OH)₂/C (Pearlman's catalyst) or increasing H₂ pressure in a Parr apparatus.

Epimerisation concern: The (3S) stereocentre in this compound is at a quaternary-like carbon bearing only C–C, C–O, and C–N bonds; it is not susceptible to base- or acid-mediated epimerisation under standard synthetic conditions. Nevertheless, confirm ee by chiral analysis after multi-step sequences.

Moisture sensitivity: The tertiary alcohol itself is not exceptionally moisture-sensitive, but reactions involving activation (e.g., mesylation) should be conducted under anhydrous conditions to prevent hydrolysis of activated intermediates.

Solvent compatibility: Avoid strongly protic acidic solvents (e.g., TFA without scavenger) which may partially cleave the Cbz group if that is not intended. Cbz is stable to aqueous base at room temperature.

Expected Results and Data Interpretation

Following successful Cbz deprotection by hydrogenolysis, the expected product is (3S)-3-methylpiperidin-3-ol as the free base. Successful reaction is indicated by disappearance of the Cbz carbonyl signal near δ 155 ppm in ¹³C NMR and loss of the benzyl CH₂ and aryl proton signals in ¹H NMR (δ ~5.1 ppm and 7.3–7.4 ppm respectively).

For functionalization of the tertiary alcohol, successful mesylation is indicated by the appearance of a methanesulfonyl singlet near δ 3.0 ppm in ¹H NMR. Optical rotation should be measured and compared against literature values where available to confirm stereochemical integrity; if no literature value is available, internal batch-to-batch comparison using the supplier CoA value is recommended.

HPLC purity of the starting material B175516 is expected to meet the specification stated on the CoA. If purity is below specification, contact Aladdin Scientific technical support and retain the original packaging for return or replacement per the returns and refunds policy.

Frequently asked questions

What solvents are recommended for dissolving benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate?

This compound is expected to dissolve readily in common polar organic solvents such as dichloromethane (DCM), tetrahydrofuran (THF), ethyl acetate, acetonitrile, and methanol. Water miscibility is limited due to the lipophilic Cbz group. Always verify solubility empirically at your working concentration.

How do I remove the Cbz protecting group from benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate?

The Cbz group is most commonly removed by catalytic hydrogenolysis using Pd/C (10 wt%) under hydrogen gas at atmospheric pressure in a protic solvent such as methanol or ethanol. The reaction typically proceeds at room temperature and is monitored by TLC or LC-MS. Pearlman's catalyst (Pd(OH)₂/C) can be used for more challenging substrates.

Will the (3S) stereocentre epimerize during standard synthetic transformations?

The C-3 stereocentre in this compound is a tertiary carbon bearing only C–C, C–O, and C–H bonds within the ring; it does not possess an acidic alpha-proton adjacent to an electron-withdrawing group in a configuration that promotes enolisation. Therefore, epimerisation under typical acidic, basic, or hydrogenolysis conditions is not expected. It is nonetheless best practice to confirm ee by chiral HPLC after each synthetic step in a multi-step sequence.

What is the recommended storage condition for SKU B175516?

As a general guideline for chiral piperidine carboxylate compounds, storage at 2–8 °C under an inert atmosphere (nitrogen or argon) and away from moisture and direct light is recommended. Always refer to the specific storage conditions stated on the Certificate of Analysis (CoA) supplied with your lot.

Can the tertiary alcohol in this compound be selectively functionalized in the presence of the Cbz-protected nitrogen?

Yes. The Cbz group on nitrogen is stable to the conditions typically used to activate or functionalize tertiary alcohols, such as mesylation or tosylation with a sulfonyl chloride and a tertiary amine base in DCM at 0 °C to room temperature. This orthogonal reactivity is one of the key synthetic advantages of this building block.

References

1. Wuts, P. G. M.; Greene, T. W. Greene's Protective Groups in Organic Synthesis, 4th ed.; Wiley-Interscience: Hoboken, NJ, 2007. (General reference for Cbz protection and deprotection strategies.)
2. Aladdin Scientific Certificate of Analysis, SKU B175516, benzyl (3S)-3-hydroxy-3-methylpiperidine-1-carboxylate. (Lot-specific purity, ee, and storage data; obtain from supplier.)
3. March, J.; Smith, M. B. March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 7th ed.; Wiley: Hoboken, NJ, 2013. (Tertiary alcohol activation and piperidine chemistry reference.)

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.